Trails Edge Capital Partners, LP

ATLANTA, GA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$695.9M2026 Q3
Positions38
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.48.7%

Trails Edge Capital Partners, LP reported 38 positions worth $695.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: LBRX (6.3%). Biggest move: new buy OBX ($34.3M).

10 / 38 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LBRXLB Pharmaceuticals$44.1M6.34%1,149,240———
▸ 2 BMRNBiomarin Pharmaceutical$40.0M5.75%667,000——-3.3%
▸ 3 NRIXNurix Therapeutics$37.3M5.36%1,573,220——-37.9%
▸ 4 OBXObsidian Therapeutics$34.3M4.92%2,495,660———
▸ 5 IMCRImmunocore$32.2M4.63%1,063,234———
▸ 6 FDMT4D Molecular Therapeutics$31.9M4.58%2,227,917——-14.5%
▸ 7 DSGNDesign Therapeutics$31.4M4.52%2,500,000———
▸ 8 CYTKCytokinetics$31.0M4.45%470,000——-19.3%
▸ 9 TRAXFirst Tracks Biotherapeutics$28.8M4.15%814,000——+32.9%
▸ 10 FTHFaeth Therapeutics$28.0M4.02%941,689——-68.8%

Pro Feature

The remaining 28 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Trails Edge Capital Partners, LP hold as of Q3 2026?

Trails Edge Capital Partners, LP reported 38 positions worth $695.9M in its Q3 2026 13F filing. Largest positions: LBRX (6.3%), BMRN (5.8%), NRIX (5.4%), OBX (4.9%) and IMCR (4.6%).

What did Trails Edge Capital Partners, LP buy in Q3 2026?

New positions: OBX, TNGX, CLDX, CTNM and TYRA (9 in all). Added to: FTH, CYTK, MLTX, AVTX and BMRN (12 in all).

What did Trails Edge Capital Partners, LP sell in Q3 2026?

Reduced: TRAX, LBRX, OKUR, IRD and XENE (7 in all). Sold out entirely: MIRM, INSM, SNDX, RVMD and INCY (6 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.